ADA Scientific Sessions 2025 Abstract

Sodium–Glucose Cotransporter 2 Inhibitor Combined with Low-Carbohydrate Diets Safely Achieves Moderate Ketosis in Healthy Volunteers—An Open-Label Pilot Study

Trial in peopleInterventions

The paper